Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.94 Analyst target: $9.50 Upside: 389.69%
Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology through its proprietary polymer-based drug delivery platform. This technology significantly enhances the efficacy of therapeutic agents, positioning Serina at the forefront of the biopharmaceutical industry. With a promising pipeline of product candidates and strategic partnerships, the company is well-equipped to drive sustainable growth and deliver impactful healthcare solutions, all while creating substantial value for its investors.
See the full interactive analysis & chart →Informational only — not investment advice.